Bleomycins
The bleomycins are a group of structurally closely related antibiotic and cytostatic effective glycopeptide derived from the bacterium Streptomyces verticillus be formed.
Structure and properties
The basic structure of bleomycins is bleomycic acid, a glycopeptide. The peptide part is made up of ten building blocks and linked glycosidically with a disaccharide consisting of L - gulose and 3 - O - carbamoyl - D - mannose . One of the characteristic features is the dithiazole ring system formed from two cysteine units.
The bleomycins are the amides of bleomycin acid, 16 natural representatives are known.
Biogenic and semi-synthetic bleomycins | |||||||||
---|---|---|---|---|---|---|---|---|---|
Basic structure of the bleomycins | |||||||||
Surname | −R | CAS number | PubChem | Molecular formula | Molar mass | ||||
|
−OH | 37364-66-2 | 2410 | C 50 H 72 N 16 O 22 S 2 | 1313.33 g mol −1 | ||||
|
![]() |
58995-26-9 | 84060 | C 54 H 81 N 17 O 22 S 3 | 1416.52 g mol −1 | ||||
|
![]() |
11116-31-7 | 5460769 | C 55 H 84 N 17 O 21 S 3 + | 1415.55 g mol −1 | ||||
|
![]() |
C 54 H 81 N 17 O 21 S 3 | 1400.52 g mol −1 | ||||||
![]() |
11116-32-8 | 84046 | C 57 H 89 N 19 O 21 S 2 | 1440.56 g mol −1 | |||||
|
37293-17-7 | 5483658 | C 60 H 96 N 20 O 21 S 2 | 1497.66 g mol −1 | |||||
|
−NH 2 | 41138-54-9 | 84052 | C 50 H 73 N 17 O 21 S 2 | 1312.35 g mol −1 | ||||
|
![]() |
9060-10-0 | 5496540 | C 55 H 84 N 20 O 21 S 2 | 1425.51 g mol −1 | ||||
|
![]() |
9060-11-1 | 84043 | C 68 H 110 N 22 O 27 S 2 | 1731.86 g mol −1 | ||||
![]() |
68247-85-8 | 6852373 | C 61 H 88 N 18 O 21 S 2 | 1473.56 g mol −1 | |||||
88266-67-5 | 16130954 | C 99 H 125 N 19 O 25 S 2 | 2045.29 g mol −1 |
Under the generic name Bleomycin , a type mixture produced by fermentation is used as a medicinal substance for the treatment of cancer diseases. It consists of at least 85% bleomycin A 2 + B 2 .
Peplomycin and liblomycin are two semisynthetic bleomycin derivatives that are not used therapeutically. Structurally related to the bleomycins are the cleomycins , talisomycins , phleomycins and zorbamycins .
Individual evidence
- ^ Theo Dingermann , Karl Hiller, Georg Schneider, Ilse Zündorf: Schneider drug drugs. 5th edition. Elsevier, Munich 2004, p. 488. ISBN 3-8274-1481-4 .